Ranch Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Ranch Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,373	Closed	-$210K	–	167
2021 Q4	$210K	Hold	1,373	–	–	0.14%	147
2021 Q3	$222K	Hold	1,373	–	–	0.14%	145
2021 Q2	$224K	Hold	1,373	–	–	0.13%	155
2021 Q1	$206K	Hold	1,373	–	–	0.14%	148
2020 Q4	$207K	Hold	1,373	–	–	0.15%	144
2020 Q3	$185K	Buy	1,373 +60	+5%	+$8.14K	0.15%	145
2020 Q2	$177K	Sell	1,313 -122	-9%	-$15.6K	0.14%	149
2020 Q1	$154K	Sell	1,435 -50	-3%	-$5.76K	0.15%	144
2019 Q4	$179K	Sell	1,485 -68	-4%	-$7.59K	0.15%	146
2019 Q3	$155K	Buy	+1,553	New	+$163K	0.17%	158

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ranch Capital Advisors's IBB Position: Q1 2022 in Review

Ranch Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,373 shares — an estimated $210K sold.

Ranch Capital Advisors first reported a position in IBB in Q3 2019 and held it in 10 quarters. The position peaked at $224K in Q2 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Ranch Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Ranch Capital Advisors sold 1,373 iShares Biotechnology ETF shares in Q1 2022, an estimated $210K.
Ranch Capital Advisors first reported a position in iShares Biotechnology ETF in Q3 2019 and held it in 10 quarters.
Ranch Capital Advisors's iShares Biotechnology ETF position peaked at $224K in Q2 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Ranch Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.